Beacon Hospital, Sandyford, Dublin 18, Ireland.
Insight Centre for Data Analytics, University College Dublin, Dublin 4, Ireland.
Sensors (Basel). 2019 Jan 21;19(2):432. doi: 10.3390/s19020432.
The majority of wearable sensor-based biofeedback systems used in exercise rehabilitation lack end-user evaluation as part of the development process. This study sought to evaluate an exemplar sensor-based biofeedback system, investigating the feasibility, usability, perceived impact and user experience of using the platform. Fifteen patients participated in the study having recently undergone knee replacement surgery. Participants were provided with the system for two weeks at home, completing a semi-structured interview alongside the System Usability Scale (SUS) and user version of the Mobile Application Rating Scale (uMARS). The analysis from the SUS (mean = 90.8 [SD = 7.8]) suggests a high degree of usability, supported by qualitative findings. The mean adherence rate was 79% with participants reporting a largely positive user experience, suggesting it offers additional support with the rehabilitation regime. Overall quality from the mean uMARS score was 4.1 out of 5 (SD = 0.39), however a number of bugs and inaccuracies were highlighted along with suggestions for additional features to enhance engagement. This study has shown that patients perceive value in the use of wearable sensor-based biofeedback systems and has highlighted the benefit of user-evaluation during the design process, illustrated the need for real-world accuracy validation, and supports the ongoing development of such systems.
大多数用于运动康复的基于可穿戴传感器的生物反馈系统在开发过程中缺乏终端用户评估。本研究旨在评估一个基于传感器的生物反馈系统范例,调查使用该平台的可行性、可用性、感知影响和用户体验。15 名最近接受过膝关节置换手术的患者参与了这项研究。参与者在家中使用该系统两周,完成了半结构化访谈以及系统可用性量表(SUS)和用户版移动应用程序评级量表(uMARS)。SUS 的分析结果(平均值=90.8[SD=7.8])表明该系统具有高度的可用性,这一结果得到了定性研究结果的支持。参与者的平均依从率为 79%,报告了非常积极的用户体验,表明该系统为康复方案提供了额外的支持。平均 uMARS 得分为 4.1 分(SD=0.39),整体质量较高,但也突出了一些错误和不准确之处,并提出了一些额外的功能来增强用户的参与度。这项研究表明,患者认为使用基于可穿戴传感器的生物反馈系统具有价值,并强调了在设计过程中进行用户评估的好处,说明了需要进行真实世界的准确性验证,并支持此类系统的持续开发。